Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01717937 · ClinicalTrials.gov registry record
Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 10
- Enrollment target
NCT01717937 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 10 participants.
The verdict
NCT01717937 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether phase variance optical coherence tomography (PV-OCT), a software-based optical coherence tomography(OCT) image processing technology, can be used to generate angiographic images of the retinochoroidal vasculature that are comparable to those produced by fluorescein angiography (FA), the current gold standard diagnostic test.
Interventions
- PROCEDURE Phase variance optical coherence tomography (PV-OCT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01717937
The ClinicalTrials.gov registry entry for NCT01717937 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Phase variance optical coherence tomography (PV-OCT) is the first listed.
NCT01717937 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01717937 about?
NCT01717937 is a clinical study titled "Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging". The purpose of this study is to determine whether phase variance optical coherence tomography (PV-OCT), a software-based optical coherence tomography(OCT) image processing technology, can be used to generate angiographic images of the retinochoroidal vasculature that are comparable to those produced...
What is the current status of trial NCT01717937?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2013-02. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01717937?
The interventions under investigation include: Phase variance optical coherence tomography (PV-OCT) (PROCEDURE).
Who is sponsoring clinical trial NCT01717937?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.